ARTELO BIOSCIENCES, INC. Quarterly Marketable Securities, Current in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Artelo Biosciences, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2020 to Q2 2024.
  • Artelo Biosciences, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $4.72M, a 42.9% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.72M -$3.55M -42.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $6.41M -$2.15M -25.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $7.61M -$1.54M -16.8% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $10.2M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.27M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $8.57M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $9.15M -$2.8M -23.4% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $12M Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.44M +$3.44M Aug 31, 2021 10-K 2023-03-31
Q2 2021 $0 May 31, 2021 10-Q 2021-07-12
Q1 2021 $512K Feb 28, 2021 10-Q 2021-04-13
Q3 2020 $0 Aug 31, 2020 10-Q 2021-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.